BMS, Eisai Team Up To Accelerate Development Of Solid-Tumor ADC

 
• By Joseph Haas
  
Lung Cancer
BMS is partnering with Eisai on an ADC with potential in solid tumors such as lung cancer
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business